Greg Duffell and Peter Stockmann of Vulcain.ai Join Vocodia Holdings Corp. as Strategic Advisors
Newsfilter· 2024-07-30 20:30
CHICAGO, July 30, 2024 (GLOBE NEWSWIRE) -- Vocodia Holdings Corp. (CBOE: VHAI), a pioneering AI software company specializing in practical AI solutions, today announced that Greg Duffell and Peter Stockmann of Vulcain.ai join Vocodia Holdings Corp. as Strategic Advisors, bringing a wealth of global expertise that will help open doors for Vocodia. Brian Podolak, Founder and CEO of Vocodia, commented, "We are excited that Greg and Peter will be joining Vocodia as strategic advisors. Each brings with them exte ...
NEXPOINT RESIDENTIAL TRUST, INC. REPORTS SECOND QUARTER 2024 RESULTS
Prnewswire· 2024-07-30 20:16
NXRT Raises Full Year 2024 Guidance, Reports Net Income of $10.6 million, $39.25 million of Disposition Activity and $14.6 million of Share Repurchase ActivityDALLAS, July 30, 2024 /PRNewswire/ -- NexPoint Residential Trust, Inc. (NYSE:NXRT) reported financial results for the second quarter ended June 30, 2024.Highlights View PDF NXRT Q2 2024 Earnings Supplement NXRT1 reported Net Income, FFO2, Core FFO2 and AFFO2 of $10.6M, $16.3M, $17.9M and $20.9M, respectively, attributable to common stockholders ...
PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024
Prnewswire· 2024-07-30 20:15
Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK, July 30, 2024 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Tuesday, August 13, 2024, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a b ...
Vislink to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024, at 8:30 a.m. ET
Newsfilter· 2024-07-30 20:15
Mt. Olive, NJ, July 30, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. ("Vislink" or the "Company") (NASDAQ:VISL), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the media and entertainment, law enforcement, and defense markets, will hold a conference call on Wednesday, August 14, 2024, at 8:30 a.m. Eastern Time to discuss its financial results for the second quarter ended June 30, 2024. Financial results will be issued in a press ...
Cassava Sciences Announces Expansion of Open-Label Extension Trials
Newsfilter· 2024-07-30 20:15
Ongoing open-label extension trials of simufilam in Alzheimer's disease to be extended by up to an additional 36 months. The extension provides participants the opportunity to continue on treatment, if they desire, pending results of the ongoing pivotal Phase 3 trials. Company plans to add cognition and plasma biomarker monitoring to the open-label extension trials to gather additional long-term data on simufilam treatment. AUSTIN, Texas, July 30, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA ...
NKGen Biotech Presents New Positive SNK01 Biomarker Data at the 2024 Alzheimer's Association International Conference
Newsfilter· 2024-07-30 20:05
SNK01, a cryopreserved autologous non-genetically modified NK cell product, is able to effectively reduce α-synuclein (α-syn) protein levels in the cerebral spinal fluid (CSF) of Alzheimer's patients; an important finding since increased α-syn has been correlated with worse cognitive performance and is not a target for any currently approved Alzheimer's treatments SNK01 treatment appears to stabilize or improve cognitive function and reduce α-synuclein levels in CSF in addition to improving previously repor ...
Better Health Outcomes for Seniors, Improved Access to Care and Reduced Environmental Footprint Are Top Achievements Noted in Alignment Healthcare's 3rd Annual ESG Report
Newsfilter· 2024-07-30 20:00
ORANGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today released its third annual environmental, social and governance (ESG) report, highlighting the Medicare Advantage (MA) company's strides to advance member care and access, reduce its environmental footprint and support the diverse needs of its members and its employees in 2023. "Leading with a serving heart is foundational to who we are as a company and how we treat our members and one another," said John Kao, f ...
Ocean Power Technologies Expands in Latin America with Reseller Agreement in Costa Rica
Newsfilter· 2024-07-30 20:00
MONROE TOWNSHIP, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE:OPTT) ("OPT" or the "Company"), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, is thrilled to announce the signing of a reseller agreement with Geos Telecom, a prominent provider of maritime communication and navigation solutions in Costa Rica. This partnership marks a significant expansion of OPT's presence in the Latin American market and includes the immediate sal ...
Viasat Introduces Wearable Secure Wireless Hub for Advanced Network and Edge Communications
Prnewswire· 2024-07-30 20:00
Secure Wireless Hub is a next-generation body-worn tactical communications system for dismounted operations CARLSBAD, Calif., July 30, 2024 /PRNewswire/ -- Viasat Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced the introduction of Viasat's Secure Wireless Hub (SWH), a wearable tactical gateway solution for dismounted soldiers that is easy to carry and simple to use. The SWH solution was developed as part of a multi-phase effort with U.S. Special Operations Command (USSOCOM) ...
PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
Prnewswire· 2024-07-30 20:00
文章核心观点 - 公司提交了一项治疗儿童和成人苯丙酮尿症(PKU)的新药申请[1][2] - 该新药临床试验数据显示可以显著降低血液中苯丙氨酸水平,并有助于患者放宽饮食限制[3] - 公司正在积极推进该新药在全球范围内的审批和上市[4] 公司概况 - 公司是一家专注于罕见疾病领域的生物制药公司[7] - 公司致力于通过创新药物的研发和全球商业化,为缺乏治疗方案的患者提供最佳治疗[7] 疾病概况 - 苯丙酮尿症是一种罕见的遗传代谢性疾病,会导致大脑损害[6] - 如果不及时治疗或管理不善,体内苯丙氨酸会积累到危险水平,造成严重不可逆的并发症[6] - 全球约有58,000人患有苯丙酮尿症[6]